Sign In
Buy BYSI
$1.74
+0.0400 (+2.35%)
At Close: Jun 03, 2026
Week In Review: Signs Of Life After Coronavirus - China Biopharma Scores $721 Million In Deals
03:58pm, Sunday, 05'th Apr 2020
Ping An announced a $311 million agreement with Japan's Shionogi to develop new drugs for infectious diseases and CNS needs based on Ping An's lifestyle data. H
Week in Review: Signs of Life After Coronavirus -- China Biopharma Scores $721 Million in Deals
09:10pm, Saturday, 04'th Apr 2020
Shanghai ZhenGe Biotech, a China CDMO, completed a $51 million Series A financing round led by Shanghai-based healthcare investment firm Lyfe Capita. The company will use the proceeds for additional h
Citigroup Inc. Has $40,000 Stock Position in Beyondspring Inc (NASDAQ:BYSI)
08:08am, Saturday, 04'th Apr 2020
Citigroup Inc. grew its stake in shares of Beyondspring Inc (NASDAQ:BYSI) by 344.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. Th
William Blair Thinks Beyondspring’s Stock is Going to Recover
03:41pm, Friday, 03'rd Apr 2020
In a report issued on March 31, Andy Hsieh from William Blair reiterated a Buy rating on Beyondspring (BYSI –
Beyondspring (BYSI) Gets a Buy Rating from H.C. Wainwright
02:58pm, Monday, 30'th Mar 2020
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Beyondspring (BYSI), with a price target of $30.00. The
Beyondspring (BYSI) Gets a Buy Rating from H.C. Wainwright
02:58pm, Monday, 30'th Mar 2020
In a report released today,
Joseph Pantginis
from H.C. Wainwright maintained a
Buy
rating on Beyondspring (
BYSI
–
Research Report
), with a price target of
$30.00
. The company’s shares closed la
BeyondSpring Initiates New Drug Application Rolling Submission for Plinabulin in China for Chemotherapy-Induced Neutropenia
12:00pm, Monday, 30'th Mar 2020
BeyondSpring Inc. (the “Company” or “BeyondSpring”) (BYSI), a global biopharmaceutical company headquartered in New York focused on the development of innovative immuno-oncology cancer therapi
-$0.42 EPS Expected for Beyondspring Inc (NASDAQ:BYSI) This Quarter
10:10am, Saturday, 28'th Mar 2020
Brokerages forecast that Beyondspring Inc (NASDAQ:BYSI) will report ($0.42) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Beyondsprin
One Thing To Remember About The BeyondSpring Inc. (NASDAQ:BYSI) Share Price
03:06pm, Thursday, 26'th Mar 2020
If you own shares in BeyondSpring Inc. (NASDAQ:BYSI) then it's worth thinking about how it contributes to the...
H.C. Wainwright Sticks to Their Buy Rating for Beyondspring (BYSI)
01:32pm, Wednesday, 25'th Mar 2020
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Beyondspring (BYSI), with a price target of $41.00. The
H.C. Wainwright Sticks to Their Buy Rating for Beyondspring (BYSI)
01:32pm, Wednesday, 25'th Mar 2020
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Beyondspring (BYSI – Research Report),
BeyondSpring Inc. (the “Company” or “BeyondSpring”) (BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that t
Charles Schwab Investment Management Inc. Boosts Position in Beyondspring Inc (NASDAQ:BYSI)
08:52am, Monday, 23'rd Mar 2020
Charles Schwab Investment Management Inc. boosted its position in shares of Beyondspring Inc (NASDAQ:BYSI) by 8.6% during the fourth quarter, Holdings Channel reports. The firm owned 27,305 shares of
Beyondspring (NASDAQ:BYSI) Earns Buy Rating from William Blair
08:00am, Monday, 23'rd Mar 2020
William Blair reiterated their buy rating on shares of Beyondspring (NASDAQ:BYSI) in a research note issued to investors on Thursday, AnalystRatings.com reports. Several other research analysts also r
50,182 Shares in Beyondspring Inc (NASDAQ:BYSI) Bought by Alyeska Investment Group L.P.
08:28am, Saturday, 21'st Mar 2020
Alyeska Investment Group L.P. acquired a new position in shares of Beyondspring Inc (NASDAQ:BYSI) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission.
